Nantahala Capital Management »

Entrada Therapeutics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.0M 159k 12.62

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Peloton Interactive Cl A Com (PTON)
Herbalife Com Shs (HLF)
Hilton Grand Vacations (HGV)
Soleno Therapeutics (SLNO)
Ban (TBBK)
Viatris Call Option (VTRS)
Edwards Lifesciences Put Option (EW)
Bioventus Com Cl A (BVS)
Establishment Labs Holdings Ord (ESTA)
Uniqure Nv SHS (QURE)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Savara (SVRA)
Spdr Series Trust State Street Spd Put Option (XBI)
Xtant Med Hldgs Com New (XTNT)

View all positions for Nantahala Capital Management

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
BlackRock
TCG Crossover Management
Vanguard Group
Vanguard Capital Management
Wellington Management Company
StepStone
Geode Capital Management
Millennium Management
State Street Corporation
Jones Hill Capital
Jacobs Levy Equity Management
Acadian Asset Management
Dimensional Fund Advisors

View all funds holding Entrada Therapeutics